Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adderall in PTSD
NCT07664631Phase 1Not yet recruiting
- Sponsor
- University of Chicago
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 1, randomised trial in post-traumatic stress disorder (PTSD) comparing placebo with Adderall (2 arms). Primary endpoints: Quality of Social Interaction Ratings using the Conversation Questionnaire at 4 hours and Quality of Social Interaction Ratings using connection during conversation scale at 4 hours. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dextroamphetamine + amphetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07664631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07664631.